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I. Introduction  
Vitamin D is an essential micronutrient that plays many important roles in the body. As a 
hormone, vitamin D regulates serum calcium and phosphate levels and influences bone health, 
cell proliferation, differentiation and apoptosis, and immune function (as reviewed in [1]). There 
are two forms of vitamin D: vitamin D2 (ergocalciferol) and D3 (cholecalciferol). The human 
body can get both vitamin D2 and D3 from diet and can also synthesize vitamin D3 in the skin 
with ultraviolet B (UVB) radiation through the sun. Skin synthesis of Vitamin D3 starts with the 
oxidation of cholesterol to 7-dehydrocholesterol. 7-dehydrocholesterol is then photolyzed by 
UVB to previtamin D3 which is then isomerized to form vitamin D3 (as reviewed in [1]). Vitamin 
D from skin synthesis or dietary sources undergoes a series of enzymatic hydroxylation to 
become biologically active. Various forms of vitamin D are transported throughout the body by 
binding to vitamin D binding protein (DBP). In the first step of vitamin D metabolism, vitamin D 
is converted to 25-hydroxyvitamin D (25(OH)D) in the liver through hydroxylation at carbon 25. 
This reaction is mainly carried out by cytochrome P450 enzyme 25-hydroxylase (CYP2R1). 
25(OH)D is the major circulating form in the body partly due to its longer half-life compared 
with other vitamin D metabolites. In the kidney, another hydroxyl group is added to carbon 1 of 
25(OH)D by cytochrome P450 enzyme 25-hydroxyvitamin D-1α-hydroxylase (CYP27B1) to 
form the biologically active 1,25-dihydroxyvitamin D (1,25(OH)2D). Next, the renal enzyme 
cytochrome P450 24-hydroxylase (CYP24A1) converts 25(OH)D and 1, 25(OH)2D to 24, 25-
dihydroxyvitamin D (24,25(OH)2D) and 1,24,25-trihydroxyvitamin D (1,24,25(OH)3D), 





An important function of vitamin D is to maintain calcium homeostasis through orchestrated 
action in the small intestine, bone, and kidney. Specifically, the parathyroid gland can sense low 
vitamin D levels and release parathyroid hormone (PTH). PTH, in turn, upregulates the 
production of 1,25(OH)2D in the kidney. As a result, the systemic level of 1,25(OH)2D rises to 
promote intestinal calcium re-absorption, trigger bone resorption for releasing calcium to the 
blood and increase renal calcium retention. When the 1,25(OH)2D level is raised to a certain 
threshold, it starts to inhibit the release of PTH from the parathyroid gland, thereby forming a 
negative feedback loop between PTH and systemic 1,25(OH)2D (Figure 2). In the meantime, 
vitamin D also has non-calcemic functions. For example, it can regulate cellular differentiation 
and elicit antiproliferative effects in bone marrow, the immune system, skin, breast and prostate 
epithelial cells, muscle and intestine (as reviewed in [1]). 





1,25(OH)2D exerts its biological effects through binding to the nuclear vitamin D receptor 
(VDR). Bound VDR became activated and enters the nucleus in the form of a homodimer or a 
VDR/RXR (retinoid X receptor) heterodimer (Figure 3). The activated VDR complex can 
regulate transcription through recognizing and binding to the vitamin D response elements 
(VDREs) in the promoter region of its target gene and subsequently recruiting other transcription 
factors. The exact sequence of VDRE varies and can determine whether it is up- or down-
regulation. It has been estimated that 300-800 genes are regulated by 1,25(OH)2D in this manner 
(as reviewed in [1]).  
 
Figure 2. Actions of PTH and vitamin D to maintain plasma calcium levels. 
 
 
Vitamin D deficiency has been associated with numerous health outcomes, including rickets in 
children, osteomalacia in adults, type 1 and type 2 diabetes, cancer, autoimmune disease and 
multiple sclerosis (as reviewed in [1]). Vitamin D status in human is most commonly estimated 
by circulating 25(OH)D. The rationale behind is that 25(OH)D is more stable than 1,25(OH)2D 
(half-life 2wks vs. less than half a day) and its circulating level is loosely regulated thereby less 
sensitive to daily activities compared with 1,25(OH)2D. Vitamin D status is affected by a number 
of factors such as diet, sun exposure, geographical location, and skin pigmentation. Emerging 
evidence shows that genetic factors can contribute to vitamin D status. Single nucleotide 
polymorphisms (SNPs) in genes important for vitamin D metabolism have been investigated for 
their associations with vitamin D metabolite levels. For instance, the rs10877012C allele in the 
CYP27B1 gene was found to be associated with lower serum 25(OH)D levels in several studies 
[2,3]. A missense mutation in exon 2 of the CYP2R1 gene was linked to increased risks of 
vitamin D deficiency [4]. Interestingly, Didriksen et al showed that individuals carrying SNP 
Figure 3. Mechanism of vitamin D actions as a nuclear signaling molecule. 
alleles associated with low baseline 25(OH)D levels in the DBP and CYP2R1 genes, were least 
responsive to vitamin D supplementation [5]. One implication of these studies is that individuals 
with specific vitamin D-related genotypes may, therefore, require personalized advice to achieve 
optimal vitamin D status. 
 
In this project, we investigated the genetic differences at genes important for vitamin D 
metabolism across 16 Collaborative Cross (CC) mouse strains (CC001, CC002, CC003, CC004, 
CC006, CC010, CC011, CC017, CC023, CC026, CC032, CC035, CC041, CC042, CC051, and 
CC052). CC strains were derived from eight founder strains (A/J, C57BL/6J, 129S1Sv/ImJ, 
NOD/ShiLtJ, NZO/H1LtJ, CAST/EiJ, PWK/PhJ, and WSB/EiJ) with the purpose of capturing 
diverse phenotypes in the mouse. Figure 4 shows an exemplary genome mosaic plot that is color-
coded for different founder origins for the CC strain CC001/Unc. Here, CC strains were selected 
to represent different basal vitamin D levels and responsiveness to vitamin D depletion. The 14 
vitamin D metabolism genes that were analyzed included genes with well-known roles in the 
vitamin D metabolism and signaling pathways (Cyp27a1, Cyp2r1, Cyp3a44, Cyp27b1, Cyp24a1, 
Vdr, Gc and Dhcr7) and genes identified by QTL mapping using the BxD recombinant inbred 
panel by Fleet et al in 2016 with poorly-studied roles in influencing serum levels of 25(OH)D 
(Plekha8 and Lyplal1), 1,25(OH)2D (Ets1 and Elac1) and FGF23 (Elac1 and Trim35) and 
responsiveness to dietary Ca restriction (Tbc1d15) [6]. The genotypes at all SNP loci in the 14 
genes were determined for the selected CC strains. Principal Component Analysis (PCA) of the 
genotypes was conducted to demonstrate genetic differences and similarities in abovementioned 
vitamin D metabolism genes among CC strains. The PCA results were then associated to vitamin 
D metabolite levels measured in two separate studies, the post-pregnancy cohort study, and the 
post-pregnancy cohort study. Genetic variations that affected basal vitamin D status and 




Determination of CC genotypes of SNPs in vitamin D metabolism genes 
Genomic locations of vitamin D metabolism genes were determined using UCSC Genome 
Browser (GRCm38/mm10). Promoter regions were defined as 1kb upstream of the transcription 
start sites. Unix shell scripts were written to extract all 15,148 SNPs at vitamin D metabolism 
genes from a dbSNP142 vcf file (Mouse Genome Project, mm10). The dbSNP142 file informs 
genotypes of the 8 CC founder strains. For each CC strain, founder origins across ~76k markers 
were individually assigned using R based on the founder contribution data (accessed from 
http://csbio.unc.edu). Lastly, CC genotypes at each extracted SNP were computed in R based on 
founder genotypes and founder origin of the SNP. 
 
Figure 4. CC strains are generated based on eight founder mouse lines. The mosaic plot 
shows the founder origins for CC001/Unc. 
Principle Component Analysis (PCA) of SNP genotypes  
PCA analyses of SNP genotypes were performed using R. Categorical data of genotype was 
converted to numerical values for PCA analysis. For each SNP locus, the most frequent genotype 
was set as the reference genotype and was coded as 1. The less frequent genotypes were coded as 
integers 2-4. Heterozygous genotype was coded as 0.5. Scores for the top 2 PCs were plotted 
using JMP, while strain clusters on PCA plots were manually assigned so that cluster 1 has the 
most strains, and cluster 2-5 contain fewer strains.   
 
Preliminary 25(OH)D measurement in post-pregnancy cohort  
Twenty-week-old mice from 17 CC strains were fed either control diet (CON, AIN-93G 
#110700, 1000 IU/kg of vitamin D3, Dyets Inc., PA) or a diet lacking vitamin D (LVD, modified 
AIN-93G diet #119266, 0 IU/kg of vitamin D3, Dyets Inc., PA). CC mice began this dietary 
treatment 5 weeks before mating and remained on these diets throughout gestation and weaning. 
At pup weaning, maternal plasma 25(OH)D was measured using ELISA (Eagle Biosciences).  
 
Vitamin D metabolites measurement in pre-pregnancy cohort  
Five-month-old CC mice were fed either control diet (CON, ENVIGO #TD.89124, 2200IU/kg of 
vitamin D3) or a diet lacking vitamin D (LVD, ENVIGO #TD.89123, 0IU/kg of vitamin D3). CC 
mice remained on treatment for 45 days. Serum from non-pregnant, unmated female CC001 and 
CC011 as well as unmated male CC006 and CC026 were collected. Seven vitamin D metabolites 
(25(OH)D3, 1,25(OH)2D3, 24,25(OH)2D3, 1,24,25(OH)3D3, e25(OH)D3, 25(OH)D2, 
1,25(OH)2D2 ) were simultaneously measured using Mass Spectrometry (Hammock Laboratory 
of Pesticide Biotechnology, UC-Davis) [7].  
 
Association between PCA clustering and vitamin D status  
Responsiveness to vitamin D depletion was estimated using % residual by normalizing vitamin 
D metabolite levels in LVD mice against average strain basal (CON) levels. ANOVA with 
Tukey’s post-hoc was used to test the effect of PCA clustering on basal vitamin D metabolites 
levels and responsiveness to dietary vitamin D depletion, separately. p-values from ANOVA 
tests were adjusted using Bonferroni correction.  
 
III. Result 
1. CC mice are genetically different at vitamin D metabolism genes 
A total of 15,148 SNPs were identified in 14 vitamin D-related genes. Out of these SNPs, 7,407 
loci were variant loci at which all 16 CC strains did not have the same genotype. Except for 
Dhcr7, Ets1, and Trim35, all genes had non-synonymous variant SNPs in coding regions. The 
number of SNPs for each gene was summarized in Table 1. 
 
Finding a suitable multivariate method is critical for properly assessing genotype differences 
across thousands of SNP loci. PCA is helpful in reducing the dimensionality of a big dataset, 
increasing interpretability but at the same time minimizing information loss [8]. It does so by 
creating new uncorrelated variables that successively maximize variance [8]. PCA performed on 
15,148 SNP loci altogether was not informative, as the top three PCs only explained less than 1% 
of the variance among CC strains. Thus, PCA was performed for SNP loci at each of the vitamin 
D metabolism gene separately. The top two PCs of each PCA analysis accounted for more than 
50% of the variance among strains for all genes. On PCA plots (Figure 5), strains in the same 
cluster are more genetically similar than those from different clusters. For instance, CC001 and 
CC002 are clustered together on the PCA plot for gene Cyp27a1, indicating that they are 
genetically similar at this gene. In this way, the 16 CC strains were distinguished by their 






Table 1. Summary of SNPs in vitamin D metabolism genes. 7,407 variant SNP loci were 












Figure 5. Plots of the top two PCs for 14 vitamin D metabolism genes. The x-axis of the plots 
indicates PC1 scores with percent variance accounted by PC1 indicated in the axis title. The 
y-axis of the plots indicates PC2 scores with percent variance accounted by PC2 indicated in 






2. Post-pregnancy cohort: PCA clusterings of Vdr and Ets1 are significantly associated with 
basal 25(OH)D levels, while PCA clusterings of Cyp24a1, Vdr and Lyplal1 are significantly 
associated with % residual 25(OH)D. 
Both basal 25(OH)D levels and % residual 25(OH)D significantly differ among the CC strains 
(Figure 6). Strains with lower % residual 25(OH)D values have a greater response to dietary 
depletion. Most strains have decreased 25(OH)D levels in response to dietary vitamin D 
depletion, except for CC047 and CC010 which have very low basal 25(OH)D levels. These non-
responders have constantly low 25(OH)D regardless of the amount of vitamin D in the diet.  
 
 




Association between PCA clustering of each gene and vitamin D status (baseline and % residual) 
was tested using ANOVA. The adjusted p-values are shown in Table 3 with significant ones 
(significance threshold 0.05) highlighted in yellow. As shown in Table 3,  PCA clusterings of 
genes Vdr and Ets1 are significantly associated with basal 25(OH)D levels in CC mice; PCA 
clusterings of Cyp24a1, Vdr, and Lylal1 are significantly associated with % residual 25(OH)D. 
According to the results from Tukey’s post-hoc test, for each of these significant comparisons, it 
is really the last group that is different from the other groups. For the 25(OH)D comparisons, the 
last groups only contain one CC006 sample. Similarly, for % residual comparisons, the last 
groups only contain one CC010 sample except for Cyp24a1 clusters.  






Table 3. PCA clustering of genes Vdr and Ets1 is significantly associated with basal 25(OH)D 
levels in CC mice. PCA clustering of Cyp24a1, Vdr, and Lylal1 is significantly associated 
with % residual 25(OH)D. 
Figure 7. Significant associations between PCA clustering and basal 25(OH)D as well as % 
residual are shown. Results from the Tukey’s post-hoc tests are shown on the figure as letter 
“a” and “b”. Strains within clusters in group “b” have a significantly higher level of basal 








3. Pre-pregnancy cohort: PCA clusterings of genes Cyp27b1, Vdr, Ets1, Elac1, Lyplal1, and 
Trim35 are significantly associated with basal 24,25(OH)2D3 levels. 
Seven vitamin D metabolites were measured simultaneously using Mass Spectrometry in the pre-
pregnancy cohort study, including 25(OH)D3, e25(OH)D3 (an epimer), 1,25(OH)2D3, 
24,25(OH)2D3, 1,24,25(OH)3D3, 25(OH)D2, and 1,25(OH)2D2. Analysis was limited to four of 
these metabolites: 25(OH)D3, 1,25(OH)2D3, 24,25(OH)2D3, and 1,24,25(OH)3D3, since the only 
vitamin D source present in both diets were vitamin D3. The analysis does not take into account 
sex factor due to lack of sex difference in vitamin D status [9]. Basal levels of 25(OH)D3 and 
24,25(OH)2D3 are significantly different among the four CC strains (Figure 8). CC026 and 
CC001 have higher basal 25(OH)D3 and 24,25(OH)2D3 levels than CC006 and CC011, and 
CC001 has an even higher basal level of 24,25(OH)2D3 than CC026 (Figure 8). Higher 
variability among samples and small sample size are likely the cause of no ANOVA significance 





Association between PCA clustering of each gene and basal levels of 25(OH)D3 and 
24,25(OH)2D3 was tested using t-test or ANOVA. Associations with significant adjusted p-
values are shown in Figure 9 (significance threshold 0.05). While none of these genes are 
significantly associated with basal 25(OH)D3 level, PCA clusterings of genes Cyp27b1, Vdr, 
Ets1, and Trim35 are significantly associated with the basal level of 24,25(OH)2D3. Strains in 
each cluster are listed under the corresponding bars in Figure 9. Based on the results from post-
hoc tests, CC001 has different 24,25(OH)2D3 level as well as different genotypes on these genes 
from the other strains. 
 
Figure 8. Basal levels of 25(OH)D3 and 24,25(OH)2D3 are significantly different among the 
four CC strains. Results from the Tukey’s post-hoc tests are shown on the figures as letter 
“a”, “b”, and “c”. Strains in one letter group have significantly different vitamin D metabolite 





IV. Discussion  
CC strains are genetically diverse at 14 genes important for vitamin D metabolism. In addition, 
they differ widely in baseline vitamin D status and susceptibility to deficiency when dietary 
sources are lacking. Specifically, we show that CC strains significantly differ in basal 25(OH)D,  
and 24,25(OH)2D3 levels and respond differently to dietary depletion based on residual 25(OH)D 
level. This suggests that CC strains are a suitable model for studying genetic determinants of 
vitamin D status.  
 
Principal component analysis is a powerful tool for assessing genotype differences across a large 
number of variant loci. However, one limitation of this method is that it does not differentiate 
between SNPs that may and may not affect protein functions, as SNPs in coding regions and 
promoter regions are more likely to alter protein structure or abundance than those in other non-
coding regions. For future direction, non-synonymous SNPs found in coding regions and SNPs 
in the promoter regions will be separately investigated.  
Figure 9. PCA clusterings of genes Cyp27b1, Vdr, Ets1, and Trim35 are significantly associated 
with the basal level of 24,25(OH)2D3. Results from the Tukey’s post-hoc tests are shown on the  
figure as letter “a” and “b”. Strains within clusters in group “a” has significantly higher basal 
level of 24,25(OH)2D3 than those in group “b”. 
 
Based on data from the post-pregnancy cohort, PCA clusterings of Vdr and Ets1 are significantly 
associated with basal 25(OH)D levels, while PCA clusterings of Cyp24a1, Vdr and Lyplal1 are 
significantly associated with % residual 25(OH)D. Speculations were made to possibly explain 
these associations. For example, Ets1 has been shown to be a transcription factor necessary for 
maximal 1,25(OH)2D induced transcription of Cyp24 gene [6]. One speculation to explain the 
association between Ets1 polymorphisms and basal 25(OH)D level is that Ets1 may influence the 
basal level of 25(OH)D by regulating Cyp24a1 to control the conversion of 25(OH)D3 to 
24,25(OH)2D. The association results from the pre-pregnancy cohort are consistent with this 
hypothesis in that we saw a significant association between PCA clustering of Ets1 and basal 
level of 24,25(OH)2D3. Vdr is associated with basal levels of 25(OH)D3 and 24,25(OH)2D3, and 
response to vitamin D depletion. Vdr protein does not directly interact with 25(OH)D3 or 
24,25(OH)2D3, but the complex of 1,25(OH)2D and Vdr binds to the vitamin D response element 
(VDRE) in Cyp24a1 and upregulates its expression [10]. Thus, it is likely that the binding 
affinity of Vdr protein to VDRE in Cyp24a1 is different across CC strains, so that certain strains 
have higher 24-hydroxylase levels and therefore lower 25(OH)D levels. This could possibly 
explain the association between Vdr polymorphisms and vitamin D status.  
 
In response to vitamin D deficiency, while expression of Cyp27b1 is upregulated by PTH, 
Cyp24a1 is likely to be downregulated since less 1,25(OH)2D is available to induce transcription 
of Cyp24a1. We speculate that the extent to which Cyp24a1 is downregulated is different across 
CC strains, which could explain why Cyp24a1 is associated with responsiveness to vitamin D 
depletion. This difference in the regulation of Cyp24a1 expression could be possibly influenced 
by the binding affinity of Vdr protein. For instance, it is likely that in certain strains, the binding 
affinity between the Vdr/1,25(OH)2D complex and the VDRE in Cyp24a1 is more sensitive to 
change in intracellular 1,25(OH)2D levels. Therefore, when 1,25(OH)2D level drops in these 
strains, 24-hydroxylase is further suppressed to maintain the reservoir of 25(OH)D. In this way, 
they exhibit less response to vitamin D depletion compared to other strains.   
 
Based on data from the pre-pregnancy cohort, PCA clusterings of genes Cyp27b1, Vdr, Ets1, and 
Trim35 are significantly associated with basal levels of 24,25(OH)2D3. These observations raised 
many questions that are worth further investigating. One of the questions is how does the 1-
hydroxylase Cyp27b1 affect the basal levels of 24,25(OH)2D3. Although, in theory, Cyp27b1 
may influence the levels of 24,25(OH)2D3  by controlling the availability of  25(OH)D3 for 24-
hydroxylation, this hypothesis is unlikely to fully explain the link between Cyp27b1 and 
24,25(OH)2D3. The reason is that, in reality, only less than one percent of 25(OH)D3 is converted 
to the bioactive form of 1,25(OH)2D3. Therefore, the extent of 1-hydroxylation of 25(OH)D3 
should only have minimal effects on basal 24,25(OH)2D3 levels. The observed link between Vdr 
and basal levels of 24,25(OH)2D3 raised another question, since Vdr does not directly control the 
metabolism of 24,25(OH)2D3. Yet, as I have speculated in the previous paragraph, the genetic 
difference in Vdr may alter its binding affinity to Cyp24a1 promoter, thereby influencing   
24,25(OH)2D3 levels through transcriptional regulation of Cyp24a1. Lastly, the link between 
Trim35 and basal 24,25(OH)2D3  may be mediated through FGF23. Trim 35 has an inhibitory 
effect on FGF23 while FGF23 can act as a transcriptional activator for Cyp24a1 to facilitate 
25(OH)D excretion [6]. Therefore, Trim35 may control basal levels of 24,25(OH)2D3 through 
regulating FGF23 and, consequently, the abundance of Cyp24a1. 
 
In both studies, we show significant difference in basal 25(OH)D levels across CC strains. 
However, the difference in % residual 25(OH)D across strains is only significant in the post-
pregnancy cohort, but not the pre-pregnancy cohort. Additionally, while the PCA clustering of 
genes Vdr and Ets1 are identified in the post-pregnancy cohort study to be significantly 
associated with the basal level of 25(OH)D, the associations are not significant in the pre-
pregnancy cohort study. These different results from the two studies are likely due to the 
different number of strains included in the analyses, different amount of vitamin D in the control 
diets, different pregnancy status of mice, and different methods for vitamin D metabolites 
measurements.   
 
In summary, we show that genetic difference at several genes regulates various vitamin D 
metabolites, including 25(OH)D3 (regulated by Vdr and Ets1), and 24,25(OH)2D3 (Cyp27b1, Vdr, 
Ets1, and Trim35). Moreover, the susceptibility to vitamin D depletion is determined by genetic 
difference at Cyp24a1, Vdr, and Lypal1. Future directions include a more focused analysis on 
SNPs in the coding regions and promoter regions since they are more likely to influence protein 
function and abundance. Additionally, the ongoing CC pre-pregnancy cohort study will include 
more strains for measurements of vitamin D metabolites and future analyses will take into 
account a potential sex effect. Strains will be selected so that they demonstrate the greatest and 
least response to vitamin D depletion. Further, expression and protein levels of candidate genes 
that could affect vitamin D status will be measured. Lastly, a genome-wide approach can be 
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